The Bidens are doing everything they can to claw back power. And now they’re making some interesting moves.
And Jill Biden was catapulted back in the spotlight for an eyebrow raising reason.
A Convenient Pivot to Women’s Health
Jill Biden, eager to move on from a tumultuous four years in the White House, has landed a cushy role as chair of the Women’s Health Network at the Milken Institute, a Santa Monica think tank that claims to tackle global health and economic issues. Her appointment comes as the Biden administration’s record—marred by questions about Joe Biden’s mental fitness and policy missteps—faces growing criticism.
“From endometriosis to healthy aging, the White House Initiative on Women’s Health Research made important investments in research and development, while making clear it will take collaboration across industries to bring these innovations to scale,” Biden said, according to a Milken Institute press release published April 29. “I am honored to join the Milken Institute as we unite leaders around a shared mission: for women everywhere to benefit from the lifesaving, world-changing research we know is possible.”
Repackaging a Flawed Initiative
The Milken Institute, styling itself as a nonpartisan hub for “financial, physical, mental, and environmental health,” has tasked Biden with steering its Women’s Health Network to foster collaboration.
As first lady, Biden pushed the Biden Cancer Moonshot and the White House Initiative on Women’s Health Research, launched in 2023 through a memorandum signed by her husband. The initiative was sold as a fix for male-biased medical research but often felt like a flashy distraction from the administration’s broader struggles.
At the Milken Institute’s 28th annual Global Conference in Beverly Hills on Monday, Biden shared the stage with figures like Trump administration officials Scott Bessent and Mehmet Oz, as well as former British Prime Minister Tony Blair. She used the platform to tout the Biden administration’s women’s health efforts, conveniently glossing over its questionable priorities and execution.
“So one of the things we did was we got to work right away,” Jill Biden said during the Milken Institute conference Monday.
“Joe said, ‘You know, let’s infuse – really, the federal government with money.’ In one year, we put in $1 billion to advance women’s research.”
Biden boasted about rejiggering National Institutes of Health research to separate gender data and securing Department of Defense funds for women’s health, all while claiming to “de-risk” investments for private equity.
Yet critics argue this was less about innovation and more about funneling taxpayer dollars into pet projects to burnish the Biden brand.
A Presidency Plagued by Doubt
Jill Biden’s new role arrives as books like 2024: How Trump Retook the White House and the Democrats Lost America and Uncharted: How Trump Beat Biden, Harris, and the Odds in the Wildest Campaign in History expose the Biden administration’s internal chaos.
Reports detail how staff shielded Joe Biden from allies and avoided cognitive testing in 2024, fearing it would amplify concerns about his age and mental decline. These revelations paint a picture of a White House more focused on optics than governance.
“And we worked a lot through the (National Institutes of Health) and the way that they did research, and we made sure that they disaggregated the data and that they separated the research on women and men differently, and we worked with (the Department of Defense) — they put a lot of money into women’s research — and then we put a lot of money in to de-risk the investment. So there were a lot of things that, really, private equity wasn’t willing to take on because it was too risky, and we thought, let’s push this forward, and let’s try to find answers more quickly,” Biden said at the conference.
Before this, Jill Biden taught at Northern Virginia Community College until December 2024, wrapping up as her husband’s presidency fizzled out.
The Milken Institute did not respond to Fox News Digital’s request for comment on her role, leaving questions about how her appointment fits into the think tank’s agenda.
